c19early.org COVID-19 treatment researchCOVID-19 treatments

Summary of COVID-19 olgotrelvir studies


1. Jiang et al., Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
1,212 patient olgotrelvir early treatment RCT: 22% improved recovery (p=0.0001).
RCT 1,212 outpatients with mild to moderate COVID-19 showing faster recovery with olgotrelvir.
May 2024, NEJM Evidence, https://evidence.nejm.org/doi/10.1056/EVIDoa2400026, https://c19p.org/jiang5